Please login to the form below
evolucumab
This page shows the latest evolucumab news and features for those working in and with pharma, biotech and healthcare.
Amgen's Repatha unclogs blocked arteries, says study
Looks to boost sales after trial shows clear clinical advantage of PCSK9 inhibitor over statins
Latest news
-
SMC rejects Amgen's Repatha over lack of outcomes data
But gives GlaxoSmithKline’s asthma drug Nucala the green light. The Scottish Medicines Consortium (SMC) has turned down Amgen's cholesterol-lowering treatment Repatha (evolucumab), citing a lack of “robust” data.
-
NICE persuaded to back Praluent as well as Repatha
drug. The scheme includes an undisclosed discount to the NHS and allows NICE to back Praluent and Amgen's rival Repatha (evolucumab), which had already agreed a price cut, in new
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Enabling Patient-Focused Research Through Virtual Clinical Trials
- Innovative Approaches to Managing Mental Health Conditions
- Newcells Biotech secures over £5m for 3D tissue models
- FDA briefing document backs J&J’s one-dose COVID-19 vaccine
- Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
- Moderna announces plans for COVID-19 variant-specific booster jabs and new production targets
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
- #DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
- Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Quick links
Infographics
